Targeted fusion biopsies have led to an improved prostate cancer (PCa) detection rate (CDR). Our aim was to assess if device-assisted fusion biopsies are superior to cognitive ones in terms of CDR. The association between multiparametric MRI parameters and PCa was also evaluated.
Prostate Cancer Detection Rate with Koelis Fusion Biopsies versus Cognitive Biopsies: A Comparative Study
ODERDA, Marco;FALETTI, Riccardo;BATTISTI, Giacomo;DALMASSO, Ettore;FALCONE, MARCO;MARRA, GIANCARLO;PALAZZETTI, ANNA;ZITELLA, Andrea;BERGAMASCO, Laura Maria;GANDINI, Giovanni;GONTERO, Paolo
Last
2016-01-01
Abstract
Targeted fusion biopsies have led to an improved prostate cancer (PCa) detection rate (CDR). Our aim was to assess if device-assisted fusion biopsies are superior to cognitive ones in terms of CDR. The association between multiparametric MRI parameters and PCa was also evaluated.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Prostate cancer detection.pdf
Accesso riservato
Tipo di file:
PDF EDITORIALE
Dimensione
459.84 kB
Formato
Adobe PDF
|
459.84 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
